Vitl, a UK-based vitamin and supplement company, has recently received a £6.5m funding injection to expand its business and reach more customers. The funding was led by Octopus Ventures, a venture capital firm that invests in innovative and disruptive companies.
Vitl was founded in 2015 with the aim of providing personalized nutrition advice and supplements to customers based on their DNA, lifestyle, and health goals. The company uses a combination of technology and expert advice to create customized vitamin packs for each customer, which are delivered to their doorstep every month.
The company’s unique approach to personalized nutrition has gained a lot of attention in recent years, with more and more people looking for ways to improve their health and wellbeing. Vitl’s products are designed to help customers achieve their health goals, whether that’s improving their energy levels, boosting their immune system, or reducing stress and anxiety.
The new funding will allow Vitl to expand its product range and reach more customers around the world. The company plans to invest in new technology and research to improve its personalized nutrition offering, as well as expanding its team and marketing efforts.
“We’re thrilled to have the support of Octopus Ventures as we continue to grow and develop our business,” said Jonathan Relph, CEO of Vitl. “Our mission is to help people live healthier, happier lives by providing personalized nutrition advice and supplements that are tailored to their individual needs. This funding will allow us to reach more people and make a real difference to their health and wellbeing.”
Vitl’s success is a testament to the growing demand for personalized nutrition and supplements. With more and more people looking for ways to improve their health and wellbeing, companies like Vitl are well-positioned to capitalize on this trend and make a real difference in people’s lives.
